首页> 外文期刊>The Journal of Infectious Diseases >Improved treatment for primary HIV infection by interferon-alfa therapy? Does HCV treatment in HIV/HCV coinfected patients help us to test this hypothesis?
【24h】

Improved treatment for primary HIV infection by interferon-alfa therapy? Does HCV treatment in HIV/HCV coinfected patients help us to test this hypothesis?

机译:通过干扰素-α疗法改善对原发性HIV感染的治疗? HIV / HCV合并感染患者的HCV治疗是否可以帮助我们检验这一假设?

获取原文
获取原文并翻译 | 示例
           

摘要

To The Editor-With great interest we read the recent study by Azzoni et al [1] and the accompanying editorial by Mc-Namara and Collins [2]. The observed antiviral effects of interferon-a on human immunodeficiency virus (HIV) load have also been well documented in the large PEG-Interferon HIV/HCV Coin-fection registration trials. Here, a drop of HIV RNA of nearly 1 log was seen in HIV viremic patients treated with pegy-lated (Peg)-interferon for hepatitis C virus (HCV) infection alone [3].
机译:致编辑-我们非常感兴趣,阅读了Azzoni等[1]的最新研究以及Mc-Namara和Collins [2]随附的社论。在大型PEG-干扰素HIV / HCV硬币感染登记试验中,也已很好地证明了观察到的干扰素-a对人体免疫缺陷病毒(HIV)的抗病毒作用。在这里,仅使用聚乙二醇化(Peg)干扰素治疗丙型肝炎病毒(HCV)感染的HIV病毒血症患者,其HIV RNA下降了近1个对数[3]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号